You are here: Industry Insights > cancer

News List

US, EU filings for Eisai’s lenvatinib in liver cancer pharmatimes
July 27, 2017
Eisai has filed its anticancer drug lenvatinib for liver cancer on both sides of the Atlantic as it seeks to expand the drug’s list of approved uses.
Roche antibody becomes first of its kind authorised for blood cancer pharmafile
July 27, 2017
NICE has announced its decision to make Roche’s Gazyvaro available via the Cancer Drugs Fund (CDF) in combination with chemotherapy for the treatment of follicular lymphoma
Sandoz expands partnership with World Child Cancer, to help children access treatment in four develo worldpharmanews
July 27, 2017
eading charity World Child Cancer, aimed at improving access to treatment and optimizing survival outcomes for children suffering from cancer in four developing countries.
Uncovering the cause of immunotherapy resistance in tumours europeanpharmaceuticalreview
July 27, 2017
Scientists have uncovered a key factor in the development of immunotherapy resistance in the case of cutaneous melanoma. This could potentially lead to future improvements in cancer therapy.
Patients at risk as UK plans to leave Euratom europeanpharmaceuticalreview
July 27, 2017
The UK’s proposed withdrawal from Euratom may threaten the supply of essential medical isotopes, putting cancer patients at risk…
Sandoz expands partnership with World Child Cancer biospectrumasia
July 27, 2017
The expanded partnership highlights Sandoz's commitment to work together with key stakeholders worldwide to expand access to healthcare.
NovellusDx collaborates with Gene Editing Institute biospectrumasia
July 26, 2017
The technology is expected to aid in identifying genetic mechanisms involved in the onset and progression of various cancer types, as well as establish high-efficacy therapy for the disease.
GIS introduces customized cancer treatment biospectrumasia
July 26, 2017
The lab will be the first in the Asia-Pacific region to focus on the integration of phenotypic data and genomic data.
Analysis of the Global Vaccine Market: With Vaccines Customized, Can We Afford Them? en-cphi.cn
July 21, 2017
The personalized cancer vaccines have been very popular in recent days, and the blockbuster results of two early studies of personalized vaccine have attracted much attention, bringing innovative treatment means and control concepts to tumors.
New way found to boost immunity in fight cancer and infections worldpharmanews
July 20, 2017
Christopher Rudd, director of research in immunology and cell therapy at Maisonneuve-Rosemont Hospital Research Centre, has identified a key new mechanism that regulates the ability of T-cells of the immune system to react against foreign antigens and can

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page